Pedro Gaspar da Costa

Dr. Pedro Gaspar da Costa

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2024 in Anaesthesia Critical Care & Pain Medicine
Verified
Journal Article
Open access
Filipe André GonzalezFilipe André Gonzalez
Filipe André Gonzalez
CSCristina Santonocito
Cristina Santonocito
TLTomas Lamas
Tomas Lamas
PCPedro Gaspar da Costa
Pedro Gaspar da Costa
Susana VieiraSusana Vieira
Susana Vieira
Filippo SanfilippoFilippo Sanfilippo
Filippo Sanfilippo
Integrating machine learning (ML) into intensive care units (ICUs) can significantly enhance patient care and operational efficiency. ML algorithms can analyze vast amounts of data from electronic health records, physiological monitoring systems, and other medical devices, providing real-time insights and predictive analytics to assist clinicians in decision-making. ML has shown promising results in predictive modeling for patient outcomes, early detection of sepsis, optimizing ventilator settings, and resource allocation. For instance, predictive algorithms have demonstrated high accuracy in forecasting patient deterioration, enabling timely interventions and reducing mortality rates. Despite these advancements, challenges such as data heterogeneity, integration with existing clinical workflows, and the need for transparency and interpretability of ML models persist. The deployment of ML in ICUs also raises ethical and legal considerations regarding patient privacy and the potential for algorithmic biases. For clinicians interested in the early embracing of AI-driven changes in clinical practice, in this review, we discuss the challenges of integrating AI and ML tools in the ICU environment in several steps and issues: 1. Main categories of ML algorithms; 2. From data enabling to ML development; 3. Decision-support systems that will allow patient stratification, accelerating the foresight of adequate individual care; 4. Improving patient outcomes and healthcare efficiency, with positive society and research implications; 5. Risks and barriers to AI-ML application to the healthcare system, including transparency, privacy, and ethical concerns.

21 March 2017 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
PCPedro Gaspar da Costa
Pedro Gaspar da Costa
FSFilipa Duarte Silva
Filipa Duarte Silva
JHJúlia Henriques
Júlia Henriques
SVSónia do Vale
Sónia do Vale
SBSandra Braz
Sandra Braz
RVRui M.M. Victorino
Rui M.M. Victorino
Adverse reactions associated to anti-thyroid drugs include fever, rash, arthralgia, agranulocytosis and hepatitis that are thought to be hypersensitivity reactions. Five cases of pleural effusion associated to thionamides have also been reported, two with propylthiouracil and three with carbimazole. We report here a case of a 75-year-old man admitted because of unilateral pleural effusion. The patient had a recent diagnosis of hyperthyroidism and 6 days after starting methimazole complained of pleuritic chest pain. He had elevated C-reactive protein and erythrocyte sedimentation rate and normal white blood cell count and liver enzymes. Chest radiography showed a moderate right pleural effusion and the ultrasound revealed a loculated effusion that was shown to be an eosinophilic exudate. The temporal relationship between methimazole intake and the development of pleural effusion combined with the extensive exclusion of alternative causes, namely infectious, neoplastic and primary auto-immune diseases, led to the diagnosis of hypersensitivity reaction to methimazole. The thionamide was stopped and corticosteroid was started with complete resolution of the pleural effusion in 3 months. Awareness of this rare adverse reaction of anti-thyroid drugs is important and methimazole can be added to the list of possible etiologies of drug-induced eosinophilic pleural effusion.

24 April 2017 in Case Reports in Critical Care
Verified
Journal Article
Open access
PDF file
PCPedro Gaspar da Costa
Pedro Gaspar da Costa
SRSofia Reimão
Sofia Reimão
SBSandra Braz
Sandra Braz
JSJoão Meneses Santos
João Meneses Santos
RVRui M. M. Victorino
Rui M. M. Victorino
Disseminated necrotizing leukoencephalopathy (DNL) is characterized by multiple microscopic foci of white matter necrosis. DNL was initially thought to be exclusively associated with immunosuppression conditions but it has been recently described in immunocompetent patients in septic shock. A 90-year-old immunocompetent woman with no previous neurological impairment presented with septic shock and drowsiness that responded well to therapy with clinical improvement and a full neurological recovery. Unexpectedly deterioration with progression to coma occurred. Investigation excluded other causes and Magnetic Resonance Imaging (MRI) was consistent with the diagnosis of DNL showing bilateral multifocal white matter lesions with a nonvascular pattern with restricted diffusion. Neurological impairment persisted with progression to death. DNL is an unexpected diagnosis in an immunocompetent patient. We compared the present case to those found in the literature of DNL complicating septic shock and discuss the antemortem diagnosis based on MRI findings.

5 May 2023 in ASAIO Journal
Verified
Journal Article
Closed access
PCPedro Gaspar da Costa
Pedro Gaspar da Costa
SRSimão C. Rodeia
Simão C. Rodeia
PFPhilip Fortuna
Philip Fortuna

1 October 2013 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
GJG. Nobre de Jesus
G. Nobre de Jesus
PCPedro Gaspar da Costa
Pedro Gaspar da Costa
LLL. Lêdo
L. Lêdo
JSJ. Meneses Santos
J. Meneses Santos
DCD. Carvalho
D. Carvalho
JCJ. Melo Cristino
J. Melo Cristino

1 October 2013 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
LLL. Lêdo
L. Lêdo
PCPedro Gaspar da Costa
Pedro Gaspar da Costa
DCD. Correia
D. Correia
SBS. Braz
S. Braz
JSJ. Meneses Santos
J. Meneses Santos
RVR.M.M. Victorino
R.M.M. Victorino